Short answer
Cartesian Therapeutics, Inc. (RNAC) filed an 8-K current report with the SEC on June 9, 2026 reporting Item 7.01 (Regulation FD Disclosure). Standard Regulation FD exhibit disclaimer covering liability under Section 18 of the Exchange Act.
Cartesian Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Standard Regulation FD exhibit disclaimer covering liability under Section 18 of the Exchange Act
- Exhibit 99.1 not incorporated into other SEC filings unless expressly referenced
- No obligation to update or amend attached materials except as legally required
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cartesian Therapeutics, Inc. 8-K filings
Get the next RNAC 8-K as it lands
Follow RNAC for push alerts, or ask the research agent what this filing means.